Skip to main content
menu
Use the COVID-19 Biobank to Support Your Coronavirus Research

Use the COVID-19 Biobank to Support Your Coronavirus Research

University of Rochester research faculty and staff can request access to thousands of COVID-19-positive and -negative blood specimens and associated, de-identified clinical data through the COVID-19 Biobank. See what the Biobank has to offer and submit a request today.  

UR CTSI Broadens Patient Cohort Discovery Capability at UR Through ACT Network

UR CTSI Broadens Patient Cohort Discovery Capability at UR Through ACT Network

University of Rochester researchers can now query de-identified data from 125 million patients across the country to validate the feasibility of their clinical trials and find collaborators for multi-site trials through the ACT Network.

COVID-19 Biobank Helps Researchers Share Patients’ Samples

COVID-19 Biobank Helps Researchers Share Patients’ Samples

The dedicated biorepository will safely collect and store serum, plasma and immune cell samples from COVID-19-positive and -negative patients. Researchers will be able to request access to the samples, which will be linked to the patients’ de-identified clinical data.

UR CTSI Offers New Electronic Medical Record Cohort Discovery Tool

UR CTSI Offers New Electronic Medical Record Cohort Discovery Tool

TriNetX provides URMC researchers with access to longitudinal clinical data in near-real-time and uses state-of-the-art analytics to identify potential study participants based on specific study criteria.

Speeding Clinical Data to Our Researchers

Speeding Clinical Data to Our Researchers

UR CTSI’s “i2b2 to REDCap” program offers researchers a way to access, sort, and export clinical data from Electronic Health Records quickly and efficiently, so they can make new discoveries faster.  

123